Innovative acute stroke care with telemedical integration of emergency services into a neurovas-cular care network

Innovative acute stroke care with telemedical integration of emergency services into a neurovas-cular care network - StroConnect

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00038989

Enrollment

3000

Registered

2026-01-21

Start date

2026-02-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected acute stroke

Interventions

Group 1: StroConnect: Prehospital tele-neurological assessment and direct transfer to endovascular-capable stroke centre of patients who are identified as candidates for endovascular thrombectomy Grou

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Prehospital suspicion of disabling acute stroke with - Face/ Arm/ Speech/ Time (FAST) score of at least 2 - Symptoms not known to have been present for > 24 hours

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Access to endovascular thrombectomy, measured as the time between ambulance arrival on scene and begin of endovascular thrombectomy (groin puncture) in patients with acute ischaemic stroke due to large vessel occlusion, right-censored at 24 h.	—

Secondary

Measure	Time frame
Secondary efficacy endpoints: # Evaluated in patients with acute stroke - Early neurological deficit (NIH stroke scale [NIHSS] score) after 24 hours - Functional outcome (modified Rankin Scale [mRS] score) after 90 days - Nondisabled (mRS score = 1) functional outcome after 90 days - Independent (mRS score = 2) functional outcome after 90 days - Health-related quality of life (PROMIS®-10) after 90 days - Depression and Anxiety (PHQ-4) after 90 days Safety endpoints: # Evaluated in all patients - Secondary transfer to a different hospital within 24 h - Neurological deficit (NIH stroke scale score) at first hospital arrival # Evaluated in patients with acute stroke - Infarct/ haematoma size - Death or dependency (mRS score 4–6) after 90 days - All-cause mortality at 90 days, time to death right-censored at 90 days # Evaluated in patients with acute ischaemic stroke - Rate of intravenous thrombolysis - Any intracranial haemorrhage within 36 hours - Symptomatic intracranial haemorrhage within 36 hours (mSITS-MOST)	—

Measure

Time frame

Secondary efficacy endpoints: # Evaluated in patients with acute stroke - Early neurological deficit (NIH stroke scale [NIHSS] score) after 24 hours - Functional outcome (modified Rankin Scale [mRS] score) after 90 days - Nondisabled (mRS score = 1) functional outcome after 90 days - Independent (mRS score = 2) functional outcome after 90 days - Health-related quality of life (PROMIS®-10) after 90 days - Depression and Anxiety (PHQ-4) after 90 days Safety endpoints: # Evaluated in all patients - Secondary transfer to a different hospital within 24 h - Neurological deficit (NIH stroke scale score) at first hospital arrival # Evaluated in patients with acute stroke - Infarct/ haematoma size - Death or dependency (mRS score 4–6) after 90 days - All-cause mortality at 90 days, time to death right-censored at 90 days # Evaluated in patients with acute ischaemic stroke - Rate of intravenous thrombolysis - Any intracranial haemorrhage within 36 hours - Symptomatic intracranial haemorrhage within 36 hours (mSITS-MOST)

—

Countries

Germany

Contacts

Public ContactKathrin Harringa

Universitätsklinikum Hamburg-Eppendorf

k.harringa@uke.de+49 152 228 293 43

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026